Systematic Characterization of Genomic Variation to Assess Effects of Individual Variants on Genome Function and Phenotype (UM1 Clinical Trials Not Allowed)
Grant Opportunity Analysis
The National Institutes of Health and the National Human Genome Research Institute are seeking cooperative agreement applications to establish Individual Variant Characterization Centers. Awardees will systematically perturb genomic variants or elements using high-throughput methods, collect data on their phenotypic effects, and develop robust, reproducible, and portable data-processing pipelines. Funded centers will join Phase 2 of the Impact of Genomic Variation on Function Consortium, which requires dedicating 20% of annual direct costs to collaborative consortium activities and assigning a dedicated Project Manager with at least 4 person-months of effort. The agency plans to commit $15 million annually to fund up to five awards, with applicants allowed to request up to $2 million in direct costs per year for a maximum five-year project period. Applications must be submitted by December 14, 2026, and questions can be directed to nhgri-igvf@mail.nih.gov.
Eligible Applicants
Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/Foreign CollaborationsNon-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed. NIH will no longer issue awards (i.e., new, renewal, or non-competing continuation) to domestic or foreign entities that involve foreign subawards/subcontracts. All NIH-funded research involving foreign subawards/subcontracts must be submitted in response to a NOFO that is specifically designated for funded international collaborations. See NIH Grants Policy Statement 16.8 Collaborative International Research Awards.Applications involving foreign subawards/subcontracts submitted in response to this NOFO will be deemed noncompliant and will not be considered for funding. This policy applies to all monetary international collaborations resulting in foreign subawards/subcontracts, however, it does not preclude unfunded international collaborations or foreign components, funding for foreign consultants, or procurement of unique equipment or supplies from foreign vendors.